Drug design is the discovery process of finding new drugs based on knowledge of biological targets. In the most basic sense, drug design involves designing molecules with shapes and charges complementary to the molecular target with which they interact and bind.
The FDA will review the information on the drug's professional label (information on how to use the drug). The FDA inspects the facility where the drug is manufactured as part of the approval process. The FDA examiner approves the application or issues in a complete response.
Ligang based drug design
Structure based drug design
Drugutilization review DUR
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
